دورية أكاديمية

P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results

التفاصيل البيبلوغرافية
العنوان: P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results
المؤلفون: Ghobrial, Irene, Rodríguez-Otero, Paula, Koh, Youngil, Martínez-López, Joaquín, Parmar, Gurdeep, Prince, Miles, Quach, Hang, de la Rubia, Javier, Hermansen, Emil, Hungria, Vania, Besisik, Sevgi Kalayoglu, Kim, Jin Seok, Leleu, Xavier, Peceliunas, Valdas, Schjesvold, Fredrik, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Oprea, Codina, Mateos, María-Victoria
المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 21, page S109-S110 ; ISSN 2152-2650
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Cancer Research, Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s2152-2650(21)02264-3
الإتاحة: https://doi.org/10.1016/s2152-2650Test(21)02264-3
https://api.elsevier.com/content/article/PII:S2152265021022643?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2152265021022643?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.21E94867
قاعدة البيانات: BASE